stockrow
Friday 6 November 2026
Export ABT’s income statement to Excel — free account
Abbott Laboratories
ABT Healthcare Medical Devices
Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024.
- Revenue
- +14.5%
- EPS
- −43.6%
- Free cash flow
- +28.9%
- Total debt
- +142.7%
Quarter to September 2026, against a year earlier
110.08
3.52
−3.10%
Follow ABT
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
12.96% | 12.33% | 10.58% | 0.00% | |
Piotroski F-Score |
5 | 4 | 4 | — | |
| 7.76% | 6.54% | 5.62% | 0.00% | ||
ROIC |
8.87% | 6.06% | 5.83% | 0.00% | |
Return on Tangible Assets |
30.61% | 32.17% | 27.80% | 0.00% | |
Average Days of Receivables |
65.29 | 66.39 | 67.37 | 0.00 | |
Free Cash Flow per Share |
4.25 | 4.23 | 4.50 | — | |
Free Cash Flow |
7,395.00 | 7,378.00 | 7,824.00 | — | |
Capital Expenditures |
(2,171.00) | (2,086.00) | (2,081.00) | — | |
| Other line items | |||||
Cash ROIC |
9.91% | 7.85% | 8.70% | — | |
Accounts Receivable Turnover |
5.97 | 5.81 | 5.62 | 0.00 | |
Accounts Payable Turnover |
4.58 | 4.44 | 4.44 | 0.00 | |
Inventory Turnover |
3.05 | 2.90 | 2.83 | 0.00 | |
Average Days of Payables |
80.11 | 86.51 | 86.57 | 0.00 | |
Days of Inventory on Hand |
122.58 | 129.22 | 132.10 | 0.00 | |
Tax Rate |
(0.23) | (0.23) | (0.28) | (0.28) | |
Research and Development Expense of Revenue |
6.64% | 6.63% | 6.78% | 6.87% | |
Selling, General and Administrative Expense of Revenue |
27.82% | 28.83% | 29.93% | 31.43% | |
Share Based Compensation of Revenue |
1.50% | 1.53% | 1.54% | 0.00% | |
Interest Coverage |
16.33 | 14.38 | 9.59 | 7.06 | |
Operating CF/Net income |
1.47 | 1.51 | 1.83 | 0.00 | |
Depreciation/Fixed assets |
0.26 | 0.26 | 0.27 | — | |
Capex/Depreciation |
(0.70) | (0.66) | (0.60) | — | |
Revenue per Share |
25.46 | 25.90 | 26.77 | 0.00 | |
Operating CF per Share |
5.49 | 5.43 | 5.69 | — | |
Capex per Share |
(1.25) | (1.20) | (1.20) | — | |
Capex to Sales |
0.05 | 0.05 | 0.04 | 0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026